{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:05:20Z","timestamp":1790499920617,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jim.2020.112869","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T12:55:44Z","timestamp":1600692944000},"page":"112869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["An in vitro refolding method to produce oligomers of anti-CHIKV, E2-IgM Fc fusion subunit vaccine candidates expressed in E. coli"],"prefix":"10.1016","volume":"487","author":[{"given":"Sandeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manohar","family":"Vasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam Shewale","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev K.","family":"Dhaked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul S.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal K.","family":"Lohiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Tapryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2020.112869_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007316","article-title":"Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice","volume":"13","author":"Arevalo","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1073\/pnas.1323166111","article-title":"Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells","volume":"111","author":"Brenner","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2020.112869_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.179.2.757","article-title":"Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3","volume":"179","author":"Bri\u00e8re","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2020.112869_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"COMMENTARY: acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jim.2020.112869_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncprheum0679","article-title":"Emerging viral infections and arthritis: the role of the rheumatologist","volume":"4","author":"Calabrese","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jim.2020.112869_bb0030","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2020.112869_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/1521-4141(200101)31:1<94::AID-IMMU94>3.0.CO;2-J","article-title":"Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro","volume":"31","author":"Choi","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2007.76.405","article-title":"Drought-associated chikungunya emergence along coastal East Africa","volume":"76","author":"Chretien","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jim.2020.112869_bb0045","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.200425719","article-title":"Decision criteria for resolving isotype switching conflicts by B cells","volume":"35","author":"Deenick","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1017\/S0950268808001167","article-title":"Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005\u20132006 outbreak on Reunion","volume":"137","author":"Economopoulou","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.jim.2020.112869_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"Erasmus","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2020.112869_bb0065","doi-asserted-by":"crossref","first-page":"S510","DOI":"10.1093\/infdis\/jiw370","article-title":"Chikungunya in the Americas: recommendations and conclusions","volume":"214","author":"Graham","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0070","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JVI.03453-13","article-title":"Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice","volume":"88","author":"Halleng\u00e4rd","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2020.112869_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11498","article-title":"Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fc\u03b1\/\u03bcR-coupled TLR4 signalling","volume":"7","author":"Honda","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jim.2020.112869_bb0080","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.1401866","article-title":"Unique ligand-binding property of the human IgM Fc receptor","volume":"194","author":"Honjo","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jim.2020.112869_bb0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"Khan","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.jim.2020.112869_bb0095","article-title":"Chikungunya: vaccines and therapeutics","volume":"6","author":"Kothila","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.jim.2020.112869_bb0100","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20091107","article-title":"Identity of the elusive IgM fc receptor (Fc\u03bcR) in humans","volume":"206","author":"Kubagawa","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2020.112869_bb0105","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.vaccine.2012.07.072","article-title":"Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus","volume":"30","author":"Kumar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2020.112869_bb0110","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.1222264110","article-title":"Involvement of Toso in activation of monocytes, macrophages, and granulocytes","volume":"110","author":"Lang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2020.112869_bb0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(14)60185-9","article-title":"Chikungunya in the Americas","volume":"383","author":"Leparc-Goffart","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2020.112869_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of chikungunya virus for use in vaccine production","volume":"4","author":"Levitt","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2020.112869_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2018.00160","article-title":"Fc\u03bc receptor promotes the survival and activation of marginal zone B cells and protects mice against bacterial sepsis","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0130","series-title":"Abstracts of the 9th Internaitonal Congress of Immunology","first-page":"87","article-title":"IL-10 induces switch towards lgG through DNA deletional rearrangement","author":"MALISAN","year":"1995"},{"key":"10.1016\/j.jim.2020.112869_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0140","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1473-3099(07)70091-9","article-title":"Chikungunya epidemic in India: a major public-health disaster","volume":"7","author":"Mavalankar","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-8-353","article-title":"Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells","volume":"8","author":"Metz","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.jim.2020.112869_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002124","article-title":"Effective chikungunya virus-like particle vaccine produced in insect cells","volume":"7","author":"Metz","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0155","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1016\/j.vaccine.2013.09.045","article-title":"Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits","volume":"31","author":"Metz","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2020.112869_bb0160","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1073\/pnas.1300547110","article-title":"High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation","volume":"110","author":"M\u00fcller","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2020.112869_bb0165","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.4049\/jimmunol.1700560","article-title":"sIgM\u2013Fc\u03bcR interactions regulate early B cell activation and plasma cell development after influenza virus infection","volume":"199","author":"Nguyen","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0170","doi-asserted-by":"crossref","first-page":"E2699","DOI":"10.1073\/pnas.1210706109","article-title":"Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses","volume":"109","author":"Ouchida","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2020.112869_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pep.2015.07.009","article-title":"Expression and characterization of the gD protein of HSV-2 fused to the tetramerization domain of the transcription factor p53","volume":"115","author":"Perez-Hernandez","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jim.2020.112869_bb0180","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1099\/vir.0.82858-0","article-title":"Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus","volume":"88","author":"Powers","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jim.2020.112869_bb0185","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0190","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2019.1574149","article-title":"51 years in of Chikungunya clinical vaccine development: a historical perspective","volume":"15","author":"Reyes-Sandoval","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.jim.2020.112869_bb0195","first-page":"177","article-title":"The Newala epidemic: III. The virus: isolation, pathogenic properties and relationship to the epidemic","volume":"54","author":"Ross","year":"1956","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.jim.2020.112869_bb0200","article-title":"Cold spring harbor protocols","volume":"2006","author":"Sambrook","year":"2006","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.jim.2020.112869_bb0205","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.jim.2020.112869_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004782","article-title":"Expression and characterization of yeast derived chikungunya virus like particles (CHIK-VLPs) and its evaluation as a potential vaccine candidate","volume":"10","author":"Saraswat","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/21645515.2015.1101197","article-title":"Chikungunya vaccines in development","volume":"12","author":"Schwameis","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.jim.2020.112869_bb0220","series-title":"Springer Seminars in Immunopathology","article-title":"Molecular and functional characteristics of the Fc\u03b1\/\u03bcR, a novel Fc receptor for IgM and IgA","volume":"Vol. 28","author":"Shibuya","year":"2006"},{"key":"10.1016\/j.jim.2020.112869_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/intimm\/dxp121","article-title":"Identification of TOSO\/FAIM3 as an Fc receptor for IgM","volume":"22","author":"Shima","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0230","series-title":"Cloning and Expression of Single Chain Antibody (ScFv) to rhGM-CSF in E. coli","author":"Tapryal","year":"2005"},{"key":"10.1016\/j.jim.2020.112869_bb0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pep.2010.03.024","article-title":"Cloning, expression and efficient refolding of carbohydrate\u2013peptide mimicry recognizing single chain antibody 2D10","volume":"72","author":"Tapryal","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jim.2020.112869_bb0240","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/infdis\/jiu114","article-title":"DNA vaccine initiates replication of live attenuated Chikungunya virus in vitro and elicits protective immune response in mice","volume":"209","author":"Tretyakova","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0245","doi-asserted-by":"crossref","first-page":"20759","DOI":"10.2807\/1560-7917.ES2014.19.13.20759","article-title":"Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe","volume":"19","author":"Van Bortel","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jim.2020.112869_bb0250","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jim.2020.112869_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","article-title":"Global expansion of chikungunya virus: mapping the 64-year history","volume":"58","author":"Wahid","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fimmu.2016.00099","article-title":"Emerging functions of natural IgM and its Fc receptor FCMR in immune homeostasis","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2020.112869_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jim.2020.112869_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003684","article-title":"A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice","volume":"9","author":"Weber","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0275","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1073\/pnas.1713166114","article-title":"Structural studies of Chikungunya virus maturation","volume":"114","author":"Yap","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2020.112869_bb0280","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3201\/eid1210.060529","article-title":"Chikungunya outbreaks caused by African genotype, India","volume":"12","author":"Yergolkar","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2020.112869_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007993","article-title":"Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA","volume":"15","author":"Young","year":"2019","journal-title":"PLoS Pathog."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175920301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175920301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:38:08Z","timestamp":1758299888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175920301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":57,"alternative-id":["S0022175920301630"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2020.112869","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in vitro refolding method to produce oligomers of anti-CHIKV, E2-IgM Fc fusion subunit vaccine candidates expressed in E. coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2020.112869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112869"}}